All.Can is a global, multi-stakeholder initiative to inform and generate political and public engagement on the need to improve the efficiency of cancer care by focusing on what really matters to patients and the society. All.Can seeks to make sure resources are directed towards achieving better health outcomes while contributing to health systems’ overall sustainability. For All.Can, efficient cancer care delivers the best possible health outcomes using the human, financial, infrastructural and technological resources available. Achieving greater efficiency allows freeing up resources that can be used to provide treatment and care that deliver the most benefit to patients, while mitigating the burden on the healthcare system and society. It involves examining what system inefficiencies exist, sharing and scaling best practices, developing evidence-based recommendations and helping to implement concrete policy actions based on these findings. Established in 2016, All.Can brings together a diverse membership base including patient organisations, healthcare professionals, academics and industry. The secretariat of All.Can is provided by Interel. All.Can International is a not-for-profit organisation (ASBL) registered in Belgium. Its work is made possible with financial support from Bristol Myers Squibb (main sponsor), Roche (major sponsor), MSD and Johnson & Johnson (sponsors), Baxter and Illumina (contributors) with additional non-financial (in kind) support from Helpsy, Intacare and Goings-On.
